The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic Drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
Schinkel, A. H., Wagenaar, E., Mol, C. A., & van Deemter, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118699 · Cited by 1,264
P-Glycoprotein, a gatekeeper in the blood–brain barrier
Schinkel, A. H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00085-4 · Cited by 960
Basic Neurochemistry: Molecular, Cellular, and Medical Aspects
Davison, A. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.8.1021-a · Cited by 941
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Litman, T., Druley, T. E., Stein, W. D., & Bates, S. E. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000912 · Cited by 688
The multidrug resistance protein family
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00167-4 · Cited by 648
Principles of Drug Action: The Basis of Pharmacology.
(1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-1-130_2 · Cited by 608
Rao, V. V., Dahlheimer, J. L., Bardgett, M. E., Snyder, A. Z., Finch, R. A., Sartorelli, A. C., & Piwnica-Worms, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3900 · Cited by 531
MDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N., Annett, G. M., & Raffel, C. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01657.x · Cited by 527
Schuetz, E. G., Beck, W. T., & Schuetz, J. D. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08713-9 · Cited by 494
Sisodiya, S. M., Lin, W. ‐., Harding, B. N., Squier, M. V., & Thom, M. (2002) · Brain · doi:10.1093/brain/awf002 · Cited by 479
Blood-brain barrier biology and methodology
Pardridge, W. M. (1999) · Journal of Neurovirology · doi:10.3109/13550289909021285 · Cited by 445
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.
Hooijberg, J. H., Broxterman, H. J., Kool, M., Assaraf, Y. G., Peters, G. J., Noordhuis, P., Scheper, R. J., Borst, P., Pinedo, H. M., & Jansen, G. (1999) · PubMed · Cited by 442
Dombrowski, S. M., Desai, S. Y., Marroni, M., Cucullo, L., Goodrich, K., Bingaman, W., Mayberg, M. R., Bengez, L., & Janigro, D. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.12301.x · Cited by 426
P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs
Fromm, M. F. (2000) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38069 · Cited by 399
Multidrug resistance transporters and modulation
Tan, B., Piwnica-Worms, D., & Ratner, L. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200009000-00011 · Cited by 384
Wijnholds, J., de Lange, E. C. M., Scheffer, G. L., van den Berg, D.-J., Mol, C. A. A. M., van der Valk, M., Schinkel, A. H., Scheper, R. J., Breimer, D. D., & Borst, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8267 · Cited by 360
Xenobiotic Transport across Isolated Brain Microvessels Studied by Confocal Microscopy
Miller, D. S., Nobmann, S. N., Gutmann, H., Toeroek, M., Drewe, J., & Fricker, G. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12708-3 · Cited by 307
Regina, A., Koman, A., Piciotti, M., El Hafny, B., Center, M. S., Bergmann, R., Couraud, P., & Roux, F. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020705.x · Cited by 266
Animal models of intractable epilepsy
Löscher, W. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00035-x · Cited by 244
Self-citationZhang, Y., Han, H., Elmquist, W. F., & Miller, D. W. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02628-7 · Cited by 236
Browne, T. R., & Holmes, G. L. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441507 · Cited by 230
Current status and future directions in the pharmacotherapy of epilepsy
Löscher, W. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01974-x · Cited by 225
Self-citationLöscher, W., & Schmidt, D. (1994) · Epilepsy Research · doi:10.1016/0920-1211(94)90012-4 · Cited by 221
Self-citationABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2
Kerb, R., Hoffmeyer, S., & Brinkmann, U. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.1.51 · Cited by 202
Potschka, H., Fedrowitz, M., & Löscher, W. (2001) · Neuroreport · doi:10.1097/00001756-200111160-00037 · Cited by 201
Self-citationExpression of Multidrug Resistance-Associated Protein (MRP) in Brain Microvessel Endothelial Cells
Huai-Yun, H., Secrest, D. T., Mark, K. S., Carney, D., Brandquist, C., Elmquist, W. F., & Miller, D. W. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.8132 · Cited by 199
Potschka, H., & Löscher, W. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.01901.x · Cited by 181
Self-citationBrown, T. (2001) · New England Journal of Medicine · Cited by 169
Decl�ves, X., Regina, A., Laplanche, J.-L., Roux, F., Boval, B., Launay, J.-M., & Scherrmann, J.-M. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000601)60:5<594::aid-jnr4>3.0.co;2-6 · Cited by 158
Seelig, A., Li‐Blatter, X., & Wohnsland, F. (2000) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38111 · Cited by 148
Carbamazepine is not a substrate for P‐glycoprotein
Owen, A., Pirmohamed, M., Tettey, J. N. A., Morgan, P., Chadwick, D. W., & Park, B. K. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01359.x · Cited by 146
The biology of the P-glycoproteins
Leveille-Webster, C., & Arias, I. M. (1995) · The Journal of Membrane Biology · doi:10.1007/bf00234655 · Cited by 115
Over-expression of Pglycoprotein in malformations of cortical development
Sisodiya, S. M., Heffernan, J. M., & Squier, M. V. (1999) · Neuroreport · doi:10.1097/00001756-199911080-00032 · Cited by 115
Drug Resistance in Epilepsy: The Role of the Blood–Brain Barrier
Abbott, N. J., Khan, E. U., Rollinson, C., Reichel, A., Janigro, D., Dombrowski, S. M., Dobbie, M. S., & Begley, D. J. (2002) · Novartis Foundation symposium · doi:10.1002/0470846356.ch4 · Cited by 109
Blood—Brain—Cerebrospinal Fluid Barriers
Laterra, J., Keep, R. F., Betz, L. A., & Goldstein, G. W. (1999) · Cited by 98
Zhang, L., Ong, W.-Y., & Lee, T. (1999) · Experimental Brain Research · doi:10.1007/s002210050759 · Cited by 97
Distribution of valproate across the interface between blood and cerebrospinal fluid
Frey, H. ‐., & Löscher, W. (1978) · Neuropharmacology · doi:10.1016/0028-3908(78)90160-0 · Cited by 88
Self-citationBrain Microvascular P-Glycoprotein and a Revised Model of Multidrug Resistance in Brain
Golden, P. L., & Pardridge, W. M. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007093521681 · Cited by 72
Potschka, H., & Löscher, W. (2001) · Neuroreport · doi:10.1097/00001756-200108080-00020 · Cited by 71
Self-citationGutmann, H., Török, M., Fricker, G., Huwyler, J., Beglinger, C., & Drewe, J. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15245-2 · Cited by 67
Transport of Fluorescein in MDCKII-MRP1 Transfected Cells and mrp1-Knockout Mice
Sun, H., Johnson, D. R., Finch, R. A., Sartorelli, A. C., Miller, D. W., & Elmquist, W. F. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5062 · Cited by 65
Drug Transport in the Mammalian Central Nervous System: Multiple Complex Systems
Spector, R. (2000) · Pharmacology · doi:10.1159/000028349 · Cited by 57
Kinetics of Penetration of Common Antiepileptic Drugs into Cerebrospinal Fluid
Löscher, W., & Frey, H. (1984) · Epilepsia · doi:10.1111/j.1528-1157.1984.tb04199.x · Cited by 56
Self-citationAdkison, K. D. K., Artru, A. A., Powers, K. M., & Shen, D. D. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39013-0 · Cited by 52
Drug delivery via the blood–brain barrier
Edwards, R. H. (2001) · Nature Neuroscience · doi:10.1038/85045 · Cited by 47
The multidrug transporters—proteins of an ancient immune system
Sarkadi, B., Müller, M., & Holló, Z. (1996) · Immunology Letters · doi:10.1016/s0165-2478(96)02676-4 · Cited by 31
Mechanisms of Drug Resistance in Epilepsy: Lessons from Oncology
Binder, D. K. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02441-8 · Cited by 25
Cited by
From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
Banks, W. A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.21 · Cited by 1,204
Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management
van Breemen, M. S., Wilms, E. B., & Vecht, C. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70103-5 · Cited by 913
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Self-citationBlood-brain barrier active efflux transporters: ATP-binding cassette gene family
Löscher, W., & Potschka, H. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.86 · Cited by 872
Self-citationThe Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
Deeken, J. F., & Löscher, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2854 · Cited by 721
Metadata
- Authors
- Löscher, W., & Potschka, H.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 301
- Issue
- 1
- Pages
- 7-14
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1967913742
- Cited by
- 409
- References
- 49
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.